BioTime, Inc.
Alameda, US
Biotech
Founders & leadership
JS
Judith SegallNamed on SEC filing
FM
Franklin M. BergerNamed on SEC filing
NC
Neal C BradsherNamed on SEC filing
RW
Robert W PeabodyNamed on SEC filing
MD
Michael D WestNamed on SEC filing
SF
Stephen FarrellNamed on SEC filing
HL
Henry L. NordhoffNamed on SEC filing
WP
William P. TewNamed on SEC filing
AC
Andrew C. von EschenbachNamed on SEC filing
PL
Pedro LichtingerNamed on SEC filing
AD
Alfred D KingsleyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2014
▶$3.5MraisedMar 2014 · 3 investors · BiotechnologyRule 506(b)
▶$3.5MraisedMar 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Judith SegallDirector
- Franklin M. BergerDirector
- Neal C BradsherDirector
- Robert W PeabodyExecutive Officer
- Michael D WestExecutive Officer, Director
- Stephen FarrellDirector
- Henry L. NordhoffDirector
- William P. TewExecutive Officer
- Andrew C. von EschenbachDirector
- Pedro LichtingerDirector
- Alfred D KingsleyDirector
- Offering amount
- $15M
- Amount sold
- $3.5M
- Minimum investment
- $500K
- First sale
- Mar 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $2.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $285.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $335.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2004 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.